InnoCare Pharma (09969) recommends adopting the 2026 RMB stock incentive plan.

date
21:20 24/04/2026
avatar
GMT Eight
Nuocheng Jianhua (09969) announced that the company suggests adopting the 2026 RMB stock incentive plan at the upcoming shareholder's annual meeting. The 2026 RMB stock incentive plan is a stock incentive plan prepared in accordance with the relevant provisions of the Securities Law, Management Measures, Science and Technology Innovation Board Listing Rules, Self-Regulation Guidelines, Hong Kong Listing Rules, and the Company's Articles of Association.
InnoCare Pharma (09969) announced that the company recommends adopting the 2026 Renminbi stock incentive plan at the upcoming annual general meeting of shareholders. The 2026 Renminbi stock incentive plan is a stock incentive plan prepared in accordance with relevant provisions of the Securities Law, Management Measures, Sci-Tech Innovation Board Listing Rules, Self-regulatory Guidelines, Hong Kong Listing Rules, and the Company's Articles of Association.